Interplay of Drug–Polymer Interactions and Release Performance for HPMCAS-Based Amorphous Solid Dispersions
Molecular Pharmaceutics · 04.03.2024 · 21 (3) · 1466-1478
DOI: 10.1021/acs.molpharmaceut.3c01106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 12.02.2024. Verfasst von Pradnya Bapat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States. Hauptthemen laut MEDLINE: Polymers, Methylcellulose. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Boehringer Ingelheim, Division of Materials Research.
Abstract (Originalsprache)
The interplay between drug and polymer chemistry and its impact on drug release from an amorphous solid dispersion (ASD) is a relatively underexplored area. Herein, the release rates of several drugs of diverse chemistry from hydroxypropyl methylcellulose acetate succinate (HPMCAS)-based ASDs were explored using surface area normalized dissolution. The tendency of the drug to form an insoluble complex with HPMCAS was determined through coprecipitation experiments. The role of pH and the extent of drug ionization were probed to evaluate the role of electrostatic interactions in complex formation. Relationships between the extent of complexation and the drug release rate from an ASD were observed, whereby the drugs could be divided into two groups. Drugs with a low extent of insoluble complex formation with HPMCAS tended to be neutral or anionic and showed reasonable release at pH 6.8 even at higher drug loadings. Cationic drugs formed insoluble complexes with HPMCAS and showed poor release when formulated as an ASD. Thus, and somewhat counterintuitively, a weakly basic drug showed a reduced release rate from an ASD at a bulk solution pH where it was ionized, relative to when unionized. The opposite trend was observed in the absence of polymer for the neat amorphous drug. In conclusion, electrostatic interactions between HPMCAS and lipophilic cationic drugs led to insoluble complex formation, which in turn resulted in ASDs with poor release performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States.
- Material and Analytical Sciences, Research and Development, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States.
ORCID-Profile: Lynne S Taylor
Förderung
- Boehringer Ingelheim
- Division of Materials Research
Zitieren
APA
Bapat, P., Paul, S., Tseng, Y. C., & Taylor, L. S. (2024). Interplay of Drug–Polymer Interactions and Release Performance for HPMCAS-Based Amorphous Solid Dispersions. Molecular Pharmaceutics, 21(3), 1466-1478. https://doi.org/10.1021/acs.molpharmaceut.3c01106
Vancouver
Bapat P, Paul S, Tseng YC, Taylor LS. Interplay of Drug–Polymer Interactions and Release Performance for HPMCAS-Based Amorphous Solid Dispersions. Molecular Pharmaceutics. 2024;21(3):1466-1478. doi:10.1021/acs.molpharmaceut.3c01106
BibTeX
@article{Bapat2024,
author = {Bapat, Pradnya and Paul, Shubhajit and Tseng, Yin-Chao and Taylor, Lynne S},
title = {Interplay of Drug–Polymer Interactions and Release Performance for HPMCAS-Based Amorphous Solid Dispersions},
journal = {Molecular Pharmaceutics},
year = {2024},
volume = {21},
number = {3},
pages = {1466--1478},
doi = {10.1021/acs.molpharmaceut.3c01106}
}
EUVIMED